ROCKEFELLER INS TITUTE In 1899, Noguchi met
Dr Simon Flexner, a physician and researcher at the University of Pennsylvania, Philadelphia, Pennsylvania, United States, who had stopped in Tokyo on his way to the Philippines. His friendship with Flexner proved to be a life-changing event. In 1901, an eager Noguchi left for Philadelphia, where he was able to land a position at the University of Pennsylvania's Department of Pathology. Noguchi's early research was on the physiologic effects of snake venom, such as haemolysis, haemorrhage, oedema and endothelial damage. After three years, Noguchi won a fellowship to study with Thorvald Madsen in Copenhagen, and upon his return a year later, joined the newly established Rockefeller Institute for Medical Research (RIMR). It turned out that its director was Flexner, his old mentor, and it was there that Noguchi launched his career in infectious disease research. Following the 1905 discovery of Treponema pallidum (T. pallidum), the causative organism of syphilis, by German scientist Fritz Schaudinn, Noguchi developed an improved diagnostic method (using complement fixation analysis) and a luetin skin test for syphilis. In 1913, Noguchi successfully isolated T. pallidum from the brains of patients with general paresis and tabes dorsalis, thus establishing the aetiology of neurosyphilis. Flexner was one of the first to be notified of this discovery, and helped to confirm that several of the slides from patients with neurosyphilis did in fact feature the spirochaete.
S Y P H I L I S
In 1910, Noguchi published a popular book on syphilis, Serum Diagnosis of Syphilis, and his findings and sketches on syphilis were subsequently reproduced in Jordan and Falk's Newer Knowledge of Bacteriology in 1928. Despite his halting English, Noguchi lectured widely before European scientists in Frankfurt, Berlin, Copenhagen, Stockholm, and London. His work in bacteriology earned him international acclaim and accolades, winning recognition from contemporary scientists such as Friedrich von Müller and Paul Ehrlich, as well as honorary degrees from several universities. However, although nominated several times for the Nobel Prize, he was never a recipient.
Noguchi has also been credited with producing an effective antiserum against Rocky Mountain spotted fever, and lauded for his research showing Bartonella bacilliformis to be the same causative agent in both Oroya fever and verruga peruviana. tackled other infectious conditions such as poliomyelitis, rabies, herpes, yellow fever and trachoma. However, none of these projects met with the same success. His initial identification of the aetiologies of poliomyelitis, trachoma, rabies, and yellow fever all proved incorrect. Of particular disappointment was his work on yellow fever. During an expedition to Ecuador in 1918, Noguchi discovered the spirochaete, Leptospira icteroides (L. icteroides), in a small percentage of patients who had been diagnosed with yellow fever. Subsequent experiments with guinea pigs, unfortunately with inadequate controls, led him to conclude that yellow fever was caused by L. icteroides. Notwithstanding the Ecuadorian government honouring him for his contributions to public health, researchers soon began to publish findings that refuted Noguchi's claim, earning him harsh criticism over his methodology, poor keeping of records, overconfidence and haste. Yellow fever was later shown to be a viral illness, and Noguchi may have confused the condition with leptospirosis.
A DARK SIDE
Noguchi's work became increasingly erratic and inaccurate. Many of his findings were not reproducible, including his claim of being able to culture the syphilis spirochaete. He was also accused of undertaking unethical human experiments such as the inoculation of leutin, an extract of syphilis, into the skin of normal children. Noguchi himself had contracted syphilis, which may have progressed to neurosyphilis, which may explain his subsequent secretiveness and paranoia. He became careless, even reckless, in the laboratory, exposing himself and his coworkers to dangerous pathogens.
